GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
146
c/glp1eu·posted 1 year ago by u/spain_receta

help me understand Apotheke, I have read the wiki twice

Question

Trying to get a straight answer on this: help me understand Apotheke, I have read the wiki twice.

How to compare prices across borders without misleading yourself.

Normalise the pack size first. Presentations differ between member states and a headline figure for one pack is not comparable to another. Then separate reimbursed from private prices, which are set by entirely different mechanisms. Then note the dispensing fee structure, which is nationally regulated.

When members here have done all three, the interesting finding has consistently been that variation between pharmacies within a country is often as large as the variation between countries — which makes the cross-border shopping most of these threads are really about far less attractive than it looks.

The structure that makes this board make sense, once.

Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.

So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.

Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.

Not medical advice, obviously, and nothing here is approved for human use. One person with a spreadsheet.

150 up / 4 down97% upvoted18 commentsid yi1vi314 Jul 2025

18 comments

14 in this archive, depth 4

best — the order this archive was captured in

u/nl_verzekering0 points·1 year ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

replysharereportpermalink
u/marisol_kravchenko1 point·1 year ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/tuva_aalto15 points·1 year ago·edited

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
u/anya_moreau8 points·1 year ago

Reimbursed or private?

replysharereportpermalink
u/still_here_20266 points·1 year ago

Reimbursed or private?

Adding the practical step — read your own country’s published criteria. They exist and they are definitive.

replysharereportpermalink
u/nikhil_asante5 points·1 year ago

say which country or the thread is useless

replysharereportpermalink
u/hydration_hank4 points·1 year ago

ask for the Beipackzettel or the local equivalent, it answers most questions

replysharereportpermalink
u/diego_iyer8 points·1 year ago

the language barrier is a real cost and nobody budgets for it

replysharereportpermalink
u/nordic_pricingMOD8 points·1 year ago

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

replysharereportpermalink
u/vomit_free_since2 points·1 year ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/line_bergstrom1 point·1 year ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
load more comments (3) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.